These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17124279)

  • 1. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
    Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM
    Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
    Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
    Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients.
    Gerrits JH; van de Wetering J; Weimar W; van Besouw NM
    Transplantation; 2009 Mar; 87(6):907-14. PubMed ID: 19300195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens.
    van Besouw NM; Vaessen LM; Zuijderwijk JM; van Vliet M; IJzermans JN; van Der Meide PH; Weimar W
    Transplantation; 2003 Apr; 75(8):1400-4. PubMed ID: 12717238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation.
    van de Wetering J; Gerrits JH; van Besouw NM; Ijzermans JN; Weimar W
    Transplantation; 2009 Mar; 87(5):740-4. PubMed ID: 19295320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granzyme B ELISPOT assay determines the cytotoxic T lymphocyte precursor frequency after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Ijzermans JN; Weimar W; van Besouw NM
    Transplant Proc; 2005 Mar; 37(2):752-4. PubMed ID: 15848521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
    Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
    Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
    Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
    Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
    Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
    Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection.
    Reinsmoen NL; Cornett KM; Kloehn R; Burnette AD; McHugh L; Flewellen BK; Matas A; Savik K
    Transplantation; 2008 Feb; 85(3):462-70. PubMed ID: 18301338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tapering immunosuppression in recipients of living donor kidney transplants.
    Weimar W; Rischen-Vos J; de Kuiper P; Gregoor PJ; IJzermans JN; van Besouw NM; Baan CC; van der Mast BJ
    Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv61-3. PubMed ID: 15240852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.